Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001387131-12-003941
Filing Date
2012-12-04
Accepted
2012-12-04 15:33:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 INFORMATION STATEMENT milligan-sc13d_113012.htm SC 13D 75684
  Complete submission text file 0001387131-12-003941.txt   77255
Mailing Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487
Business Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487 561-961-1911
TherapeuticsMD, Inc. (Subject) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-32384 | Film No.: 121240547
SIC: 2834 Pharmaceutical Preparations

Mailing Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487
Business Address
Milligan John C.K. IV (Filed by) CIK: 0001532230 (see all company filings)

Type: SC 13D